Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus

被引：2
作者：
Farinha, F. [1 ]
Abrol, E. [2 ]
Isenberg, D. A. [3 ]
机构：
[1] Ctr Hosp Baixo Vouga EPE, Dept Rheumatol, Aveiro, Portugal
[2] Kings Coll Hosp NHS Fdn Trust, PRUH, London, England
[3] UCL, Div Med, Ctr Rheumatol, London, England
来源：
LUPUS | 2016年 / 25卷 / 11期
关键词：
RITUXIMAB; EFFICACY; SAFETY;
D O I：
10.1177/0961203316631636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1278 / 1279
页数：2
相关论文
共 50 条
  • [41] Manage the neuropsychiatric manifestations of systemic lupus erythematosus with mostly empirical treatments
    Drugs & Therapy Perspectives, 2012, 28 (5) : 11 - 14
  • [42] Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives
    Nikolopoulos, Dionysis
    Fanouriakis, Antonis
    Bertsias, George
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (04) : 317 - 329
  • [43] Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
    Petricca, Luca
    Gigante, Maria Rita
    Paglionico, Annamaria
    Costanzi, Stefano
    Vischini, Gisella
    Di Mario, Clara
    Varriano, Valentina
    Tanti, Giacomo
    Tolusso, Barbara
    Alivernini, Stefano
    Grandaliano, Giuseppe
    Ferraccioli, Gianfranco
    Gremese, Elisa
    FRONTIERS IN MEDICINE, 2020, 7
  • [44] Infections in patients with systemic lupus erythematosus
    Enberg G, Margarita
    Kahn Ch, Mariana
    Goity F, Cecilia
    Valentina Villalon S, Maria
    Zamorano R, Juanita
    Figueroa E, Fernando
    REVISTA MEDICA DE CHILE, 2009, 137 (10) : 1367 - 1374
  • [45] Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis
    Mo, Shouqi
    Li, Yilan
    He, Junbing
    Lin, Ling
    FRONTIERS IN MEDICINE, 2024, 11
  • [46] Target Therapies in Systemic Lupus Erythematosus: Current State of the Art
    Wiesik-Szewczyk, E.
    Lacki, J. K.
    Feleszko, W.
    Olesinska, M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (10) : 956 - 965
  • [47] The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?
    Lorenzo-Vizcaya, Ana
    Isenberg, David A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (05) : 639 - 647
  • [48] New developments in the treatment of systemic lupus erythematosus
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2012, 27 (05) : 727 - 732
  • [49] Innovations in the pharmaceutical treatment of systemic lupus erythematosus
    Mucke, Johanna
    Schneider, Matthias
    INTERNIST, 2022, 63 (05): : 566 - 572
  • [50] An era of biological treatment in systemic lupus erythematosus
    He, Jing
    Li, Zhanguo
    CLINICAL RHEUMATOLOGY, 2018, 37 (01) : 1 - 3
12345